Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMALIZUMAB for Dermatitis atopic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 199 adverse event reports in the FDA FAERS database where OMALIZUMAB was used for Dermatitis atopic.

Most Reported Side Effects for OMALIZUMAB

Side Effect Reports % Deaths Hosp.
No adverse event 9,736 15.3% 0 3
Asthma 9,354 14.7% 208 4,275
Urticaria 9,231 14.5% 39 1,723
Off label use 9,199 14.4% 100 627
Dyspnoea 8,323 13.0% 133 3,674
Drug ineffective 6,747 10.6% 57 1,465
Cough 5,926 9.3% 86 2,751
Pruritus 5,224 8.2% 32 1,202
Fatigue 5,053 7.9% 94 1,826
Malaise 4,820 7.6% 113 2,032
Wheezing 4,522 7.1% 78 2,000
Headache 4,416 6.9% 47 1,505
Pneumonia 4,251 6.7% 133 2,318
Pain 3,605 5.7% 46 1,198
Nasopharyngitis 3,421 5.4% 48 1,472

Other Indications for OMALIZUMAB

Asthma (24,041) Product used for unknown indication (14,050) Chronic spontaneous urticaria (9,063) Idiopathic urticaria (8,366) Urticaria (5,500) Urticaria chronic (1,064) Food allergy (624) Angioedema (412) Hypersensitivity (364) Rhinitis allergic (305)

Other Drugs Used for Dermatitis atopic

DUPILUMAB (179,563) UPADACITINIB (5,263) TRALOKINUMAB-LDRM (3,007) CRISABOROLE (2,139) ABROCITINIB (1,616) NEMOLIZUMAB-ILTO (1,596) RUXOLITINIB (740) TACROLIMUS (515) METHOTREXATE (400) CYCLOSPORINE (370)

Related Pages

OMALIZUMAB Full Profile All Dermatitis atopic Drugs OMALIZUMAB Demographics OMALIZUMAB Timeline